GSK expands its board with renowned cancer...British pharma company GlaxoSmithKline plc. is expanding its company board and announced Laurie Glimcher as a non-executive director. Glimcher will join the board on 1 September. more ➔
Sygnis AG: Science and business rolled int...German-Spanish biotech Sygnis AG has made changes to its management team and supervisory board. Heikki Lanckriet, who was previously Co-CEO, will become sole CEO of Sygnis and will also retain his role … more ➔
Tiziana Life Sciences: Putting research fi...AIM-listed Tiziana Life Sciences has a new head: The clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases appointed Kunwar Shailubhai Chief Executive Officer … more ➔
Ablynx: Chief of businessBelgian biopharmaceutical company Ablynx named Markus L.E. Ewert Chief Business Officer (CBO). Effective from 20 June 2017, Dr Ewert will lead the Company’s business development and corporate strategy … more ➔
SOBI: Business ManRare disease drug developer Swedish Orphan Biovitrum AB (Sobi) has named Guido Oelkers as the companys new President and CEO. Oelkers, who holds a PhD in Strategic Management from the University of … more ➔
uniQure: Doctors ordersDutch gene therapy developer uniQure has appointed Steven l. Zelenkofske as its Chief Medical Officer. more ➔
Recipharm: Strategic appointmentContract development and manufacturing organisation Recipharm has appointed Shabbir Mostafa as Director, Business Management UK & Ireland. He will be responsible for supporting customers in the UK … more ➔
Virbac: Managing global operationsFrench vet-med maker Virbac has named Frédéric Jodogne as Corporate Industrial Operations director in early April. He is in charge of implementing, organizing and leading supply chain and industrial … more ➔
Luminary in vaccine researchJan Holmgren, developer of the first effective oral cholera vaccine, has been awarded the 2017 Sabin Gold Medal for his pioneering contributions to oral vaccine research and mucosal immunology, and his … more ➔
Pharmalink: Launching into Phase IIIPharmalink AB has hired Renee Aguiar-Lucander as Chief Executive Officer. She will lead the expansion and strategic development of the Swedish specialty pharmaceutical company following the clinical … more ➔
